Licensed Vocational Nurse in Buffalo, NY Accepting Medicare

5 Licensed Vocational Nurse nurses found. Showing 1 - 5

Mildred Iyasere, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 69 Delaware Ave, 1200, Buffalo, NY 14202 Phone: 716-852-5900

Donnetta N,g Willet, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Rees St, Buffalo, NY 14213 Phone: 716-884-3445

Michelle Lee White, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Forest Ave, Buffalo, NY 14213 Phone: 716-816-2445    Fax: 716-816-2537

Mrs. Gloria Ann Jones, L..P.N Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 97 Wex Ave, Buffalo, NY 14211 Phone: 716-896-1718

Chante Crawford, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 170 Franklin St, Suite 501, Buffalo, NY 14202 Phone: 716-856-2702    Fax: 716-856-8034

News Archive

Brazilian plant extract fights Candidiasis

There are many fungi that live in the body that make up the normal body microbial flora. One type, Candida, a type of yeast, normally thrives in small amounts in areas such as the skin, abdomen, and mouth, without causing any problem. But, when the body's environment is altered, the yeast can uncontrollably proliferate and cause disease.

Discovery of key mechanism in bacterial communication

A team of Princeton scientists has discovered a key mechanism in how bacteria communicate with each other, a pivotal breakthrough that could lead to treatments for cholera and other bacterial diseases.

Mayo Clinic Women's HealthSource discusses myths and facts about ovarian cancer

But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.

Abbott and Enanta's ABT-450/r Phase 2 study results against HCV presented at EASL meeting

Abbott and Enanta Pharmaceuticals today announced 12-week results from a Phase 2 study of ABT-450/r, an investigational, oral protease inhibitor being developed for the treatment of hepatitis C infection.

Party, policy leaders take key positions in fight over health overhaul's future

In a battle that has near- and long-term implications, party leaders flex their muscles. Meanwhile, centrists launch a new program to advance the development of state exchanges.

Read more Medical News

› Verified 1 days ago